Colgate-Palmolive Company (NYSE: CL) Stock Competitors & Peer Comparison
See CL's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CL and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CL | $86.46 | -0.07% | 69.2B | 23.06 | $3.75 | +2.44% |
| PG | $148.32 | -0.48% | 352.7B | 21.38 | $6.94 | +2.90% |
| UL | $61.24 | -2.06% | 132B | 20.42 | $3.00 | +3.63% |
| KVUE | $17.91 | +0.14% | 34.4B | 15.18 | $1.18 | +5.84% |
| EL | $94.37 | -1.26% | 34.1B | 42.70 | $2.21 | +1.48% |
| KMB | $98.99 | +0.22% | 32.9B | 13.29 | $7.45 | +5.17% |
| CHD | $94.95 | -0.70% | 22.5B | 26.67 | $3.56 | +1.28% |
| CLX | $81.60 | +0.22% | 9.9B | 14.73 | $5.54 | +6.12% |
| ELF | $101.70 | -0.10% | 6B | 25.48 | $3.99 | N/A |
| REYN | $22.07 | -0.05% | 4.7B | 12.91 | $1.71 | +4.19% |
Stock Comparison
The Procter & Gamble Company (NYSE: PG)
CL vs PG Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, PG has a market cap of 352.7B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while PG trades at $148.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas PG's P/E ratio is 21.38. In terms of profitability, CL's ROE is +6.31%, compared to PG's ROE of +0.30%. Regarding short-term risk, CL is less volatile compared to PG. This indicates lower risk in terms of short-term price fluctuations for CL.Check PG's competition here
Unilever PLC (NYSE: UL)
CL vs UL Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, UL has a market cap of 132B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while UL trades at $61.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas UL's P/E ratio is 20.42. In terms of profitability, CL's ROE is +6.31%, compared to UL's ROE of +0.37%. Regarding short-term risk, CL is more volatile compared to UL. This indicates higher risk in terms of short-term price fluctuations for CL.Check UL's competition here
Kenvue Inc. (NYSE: KVUE)
CL vs KVUE Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, KVUE has a market cap of 34.4B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while KVUE trades at $17.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas KVUE's P/E ratio is 15.18. In terms of profitability, CL's ROE is +6.31%, compared to KVUE's ROE of +0.16%. Regarding short-term risk, CL is less volatile compared to KVUE. This indicates lower risk in terms of short-term price fluctuations for CL.Check KVUE's competition here
The Estée Lauder Companies Inc. (NYSE: EL)
CL vs EL Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, EL has a market cap of 34.1B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while EL trades at $94.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas EL's P/E ratio is 42.70. In terms of profitability, CL's ROE is +6.31%, compared to EL's ROE of +0.05%. Regarding short-term risk, CL is less volatile compared to EL. This indicates lower risk in terms of short-term price fluctuations for CL.Check EL's competition here
Kimberly-Clark Corporation (NASDAQ: KMB)
CL vs KMB Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, KMB has a market cap of 32.9B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while KMB trades at $98.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas KMB's P/E ratio is 13.29. In terms of profitability, CL's ROE is +6.31%, compared to KMB's ROE of +1.23%. Regarding short-term risk, CL is less volatile compared to KMB. This indicates lower risk in terms of short-term price fluctuations for CL.Check KMB's competition here
Church & Dwight Co., Inc. (NYSE: CHD)
CL vs CHD Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, CHD has a market cap of 22.5B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while CHD trades at $94.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas CHD's P/E ratio is 26.67. In terms of profitability, CL's ROE is +6.31%, compared to CHD's ROE of +0.18%. Regarding short-term risk, CL is less volatile compared to CHD. This indicates lower risk in terms of short-term price fluctuations for CL.Check CHD's competition here
The Clorox Company (NYSE: CLX)
CL vs CLX Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, CLX has a market cap of 9.9B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while CLX trades at $81.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas CLX's P/E ratio is 14.73. In terms of profitability, CL's ROE is +6.31%, compared to CLX's ROE of -18.94%. Regarding short-term risk, CL is less volatile compared to CLX. This indicates lower risk in terms of short-term price fluctuations for CL.Check CLX's competition here
e.l.f. Beauty, Inc. (NYSE: ELF)
CL vs ELF Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, ELF has a market cap of 6B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while ELF trades at $101.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas ELF's P/E ratio is 25.48. In terms of profitability, CL's ROE is +6.31%, compared to ELF's ROE of +0.05%. Regarding short-term risk, CL is less volatile compared to ELF. This indicates lower risk in terms of short-term price fluctuations for CL.Check ELF's competition here
Reynolds Consumer Products Inc. (NASDAQ: REYN)
CL vs REYN Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, REYN has a market cap of 4.7B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while REYN trades at $22.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas REYN's P/E ratio is 12.91. In terms of profitability, CL's ROE is +6.31%, compared to REYN's ROE of +0.15%. Regarding short-term risk, CL is less volatile compared to REYN. This indicates lower risk in terms of short-term price fluctuations for CL.Check REYN's competition here
Natura &Co Holding S.A. (NYSE: NTCO)
CL vs NTCO Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas NTCO's P/E ratio is -11.37. In terms of profitability, CL's ROE is +6.31%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, CL is less volatile compared to NTCO. This indicates lower risk in terms of short-term price fluctuations for CL.Check NTCO's competition here
Inter Parfums, Inc. (NASDAQ: IPAR)
CL vs IPAR Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, IPAR has a market cap of 3.7B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while IPAR trades at $115.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas IPAR's P/E ratio is 22.01. In terms of profitability, CL's ROE is +6.31%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, CL is less volatile compared to IPAR. This indicates lower risk in terms of short-term price fluctuations for CL.Check IPAR's competition here
Coty Inc. (NYSE: COTY)
CL vs COTY Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, COTY has a market cap of 2.4B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while COTY trades at $2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas COTY's P/E ratio is 14.97. In terms of profitability, CL's ROE is +6.31%, compared to COTY's ROE of -0.18%. Regarding short-term risk, CL is less volatile compared to COTY. This indicates lower risk in terms of short-term price fluctuations for CL.Check COTY's competition here
Newell Brands Inc. (NASDAQ: NWL)
CL vs NWL Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, NWL has a market cap of 2.3B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while NWL trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas NWL's P/E ratio is 9.85. In terms of profitability, CL's ROE is +6.31%, compared to NWL's ROE of -0.09%. Regarding short-term risk, CL is less volatile compared to NWL. This indicates lower risk in terms of short-term price fluctuations for CL.Check NWL's competition here
Spectrum Brands Holdings, Inc. (NYSE: SPB)
CL vs SPB Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while SPB trades at $80.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas SPB's P/E ratio is 12.40. In terms of profitability, CL's ROE is +6.31%, compared to SPB's ROE of +0.04%. Regarding short-term risk, CL is less volatile compared to SPB. This indicates lower risk in terms of short-term price fluctuations for CL.Check SPB's competition here
Edgewell Personal Care Company (NYSE: EPC)
CL vs EPC Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while EPC trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas EPC's P/E ratio is 14.95. In terms of profitability, CL's ROE is +6.31%, compared to EPC's ROE of -0.06%. Regarding short-term risk, CL is less volatile compared to EPC. This indicates lower risk in terms of short-term price fluctuations for CL.Check EPC's competition here
Oddity Tech Ltd. (NASDAQ: ODD)
CL vs ODD Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, ODD has a market cap of 1B. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while ODD trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas ODD's P/E ratio is 13.77. In terms of profitability, CL's ROE is +6.31%, compared to ODD's ROE of +0.05%. Regarding short-term risk, CL is less volatile compared to ODD. This indicates lower risk in terms of short-term price fluctuations for CL.Check ODD's competition here
Helen of Troy Limited (NASDAQ: HELE)
CL vs HELE Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, HELE has a market cap of 655.7M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while HELE trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas HELE's P/E ratio is 8.53. In terms of profitability, CL's ROE is +6.31%, compared to HELE's ROE of -0.48%. Regarding short-term risk, CL is less volatile compared to HELE. This indicates lower risk in terms of short-term price fluctuations for CL.Check HELE's competition here
The Honest Company, Inc. (NASDAQ: HNST)
CL vs HNST Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, HNST has a market cap of 573.5M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while HNST trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas HNST's P/E ratio is 81.67. In terms of profitability, CL's ROE is +6.31%, compared to HNST's ROE of -0.07%. Regarding short-term risk, CL is less volatile compared to HNST. This indicates lower risk in terms of short-term price fluctuations for CL.Check HNST's competition here
Magnera Corp (NYSE: MAGN)
CL vs MAGN Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, MAGN has a market cap of 414.2M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while MAGN trades at $11.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas MAGN's P/E ratio is -5.63. In terms of profitability, CL's ROE is +6.31%, compared to MAGN's ROE of -0.11%. Regarding short-term risk, CL is less volatile compared to MAGN. This indicates lower risk in terms of short-term price fluctuations for CL.Check MAGN's competition here
Prenetics Global Limited (NASDAQ: PRE)
CL vs PRE Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, PRE has a market cap of 388.3M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while PRE trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas PRE's P/E ratio is -5.64. In terms of profitability, CL's ROE is +6.31%, compared to PRE's ROE of -0.49%. Regarding short-term risk, CL is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for CL.Check PRE's competition here
European Wax Center, Inc. (NASDAQ: EWCZ)
CL vs EWCZ Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, CL's ROE is +6.31%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, CL is more volatile compared to EWCZ. This indicates higher risk in terms of short-term price fluctuations for CL.Check EWCZ's competition here
Prenetics Global Limited (NASDAQ: PRENW)
CL vs PRENW Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, PRENW has a market cap of 267.7M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas PRENW's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to PRENW's ROE of -0.49%. Regarding short-term risk, CL is more volatile compared to PRENW. This indicates higher risk in terms of short-term price fluctuations for CL.Check PRENW's competition here
Acme United Corporation (AMEX: ACU)
CL vs ACU Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, ACU has a market cap of 242.6M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while ACU trades at $63.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas ACU's P/E ratio is 27.44. In terms of profitability, CL's ROE is +6.31%, compared to ACU's ROE of +0.08%. Regarding short-term risk, CL is less volatile compared to ACU. This indicates lower risk in terms of short-term price fluctuations for CL.Check ACU's competition here
Yatsen Holding Limited (NYSE: YSG)
CL vs YSG Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, YSG has a market cap of 237.8M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while YSG trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas YSG's P/E ratio is -19.85. In terms of profitability, CL's ROE is +6.31%, compared to YSG's ROE of -0.07%. Regarding short-term risk, CL is less volatile compared to YSG. This indicates lower risk in terms of short-term price fluctuations for CL.Check YSG's competition here
Nu Skin Enterprises, Inc. (NYSE: NUS)
CL vs NUS Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, NUS has a market cap of 223.3M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while NUS trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas NUS's P/E ratio is 3.83. In terms of profitability, CL's ROE is +6.31%, compared to NUS's ROE of -0.29%. Regarding short-term risk, CL is less volatile compared to NUS. This indicates lower risk in terms of short-term price fluctuations for CL.Check NUS's competition here
Pitanium Limited (NASDAQ: PTNM)
CL vs PTNM Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas PTNM's P/E ratio is 346.33. In terms of profitability, CL's ROE is +6.31%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, CL is more volatile compared to PTNM. This indicates higher risk in terms of short-term price fluctuations for CL.Check PTNM's competition here
Waldencast plc (NASDAQ: WALD)
CL vs WALD Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, WALD has a market cap of 109.7M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while WALD trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas WALD's P/E ratio is -0.46. In terms of profitability, CL's ROE is +6.31%, compared to WALD's ROE of -0.48%. Regarding short-term risk, CL is less volatile compared to WALD. This indicates lower risk in terms of short-term price fluctuations for CL.Check WALD's competition here
Solesence, Inc. Common Stock (NASDAQ: SLSN)
CL vs SLSN Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, SLSN has a market cap of 57.9M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while SLSN trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas SLSN's P/E ratio is 66.67. In terms of profitability, CL's ROE is +6.31%, compared to SLSN's ROE of -0.12%. Regarding short-term risk, CL is less volatile compared to SLSN. This indicates lower risk in terms of short-term price fluctuations for CL.Check SLSN's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV)
CL vs GROV Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, GROV has a market cap of 45M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while GROV trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas GROV's P/E ratio is -5.63. In terms of profitability, CL's ROE is +6.31%, compared to GROV's ROE of -0.83%. Regarding short-term risk, CL is less volatile compared to GROV. This indicates lower risk in terms of short-term price fluctuations for CL.Check GROV's competition here
Axil Brands, Inc. (AMEX: AXIL)
CL vs AXIL Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, AXIL has a market cap of 42.9M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while AXIL trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas AXIL's P/E ratio is 52.46. In terms of profitability, CL's ROE is +6.31%, compared to AXIL's ROE of +0.24%. Regarding short-term risk, CL is less volatile compared to AXIL. This indicates lower risk in terms of short-term price fluctuations for CL.Check AXIL's competition here
United-Guardian, Inc. (NASDAQ: UG)
CL vs UG Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, UG has a market cap of 33.2M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while UG trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas UG's P/E ratio is 13.88. In terms of profitability, CL's ROE is +6.31%, compared to UG's ROE of +0.22%. Regarding short-term risk, CL is less volatile compared to UG. This indicates lower risk in terms of short-term price fluctuations for CL.Check UG's competition here
Waldencast plc (NASDAQ: WALDW)
CL vs WALDW Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, WALDW has a market cap of 26.9M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while WALDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas WALDW's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to WALDW's ROE of -0.48%. Regarding short-term risk, CL is less volatile compared to WALDW. This indicates lower risk in terms of short-term price fluctuations for CL.Check WALDW's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSY)
CL vs DSY Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, DSY has a market cap of 17.1M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while DSY trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas DSY's P/E ratio is -0.40. In terms of profitability, CL's ROE is +6.31%, compared to DSY's ROE of +14.77%. Regarding short-term risk, CL is less volatile compared to DSY. This indicates lower risk in terms of short-term price fluctuations for CL.Check DSY's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSYWW)
CL vs DSYWW Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, DSYWW has a market cap of 14.3M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while DSYWW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas DSYWW's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, CL is more volatile compared to DSYWW. This indicates higher risk in terms of short-term price fluctuations for CL.Check DSYWW's competition here
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH)
CL vs PHH Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, PHH has a market cap of 10M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas PHH's P/E ratio is -0.53. In terms of profitability, CL's ROE is +6.31%, compared to PHH's ROE of +0.38%. Regarding short-term risk, CL is less volatile compared to PHH. This indicates lower risk in terms of short-term price fluctuations for CL.Check PHH's competition here
Tantech Holdings Ltd (NASDAQ: TANH)
CL vs TANH Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, TANH has a market cap of 9.6M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while TANH trades at $14.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas TANH's P/E ratio is 1.63. In terms of profitability, CL's ROE is +6.31%, compared to TANH's ROE of -0.25%. Regarding short-term risk, CL is less volatile compared to TANH. This indicates lower risk in terms of short-term price fluctuations for CL.Check TANH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSH)
CL vs BRSH Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas BRSH's P/E ratio is -0.01. In terms of profitability, CL's ROE is +6.31%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, CL is less volatile compared to BRSH. This indicates lower risk in terms of short-term price fluctuations for CL.Check BRSH's competition here
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH)
CL vs BYAH Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, BYAH has a market cap of 1.8M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while BYAH trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas BYAH's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to BYAH's ROE of -1.74%. Regarding short-term risk, CL is less volatile compared to BYAH. This indicates lower risk in terms of short-term price fluctuations for CL.Check BYAH's competition here
Instinct Bio Technical Co. Holdings Inc. (NASDAQ: BIOT)
CL vs BIOT Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, BIOT has a market cap of 1.6M. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while BIOT trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas BIOT's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to BIOT's ROE of -1217.55%. Regarding short-term risk, CL is less volatile compared to BIOT. This indicates lower risk in terms of short-term price fluctuations for CL.Check BIOT's competition here
Instinct Bio Technical Company Holdings Inc. Warrants (NASDAQ: BIOTW)
CL vs BIOTW Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, BIOTW has a market cap of 68.9K. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while BIOTW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas BIOTW's P/E ratio is -0.09. In terms of profitability, CL's ROE is +6.31%, compared to BIOTW's ROE of -1217.55%. Regarding short-term risk, CL is less volatile compared to BIOTW. This indicates lower risk in terms of short-term price fluctuations for CL.Check BIOTW's competition here
Bruush Oral Care Inc. (NASDAQ: BRSHW)
CL vs BRSHW Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas BRSHW's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, CL is less volatile compared to BRSHW. This indicates lower risk in terms of short-term price fluctuations for CL.Check BRSHW's competition here
Elizabeth Arden, Inc. (NASDAQ: RDEN)
CL vs RDEN Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, RDEN has a market cap of 0. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas RDEN's P/E ratio is -5.68. In terms of profitability, CL's ROE is +6.31%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, CL is more volatile compared to RDEN. This indicates higher risk in terms of short-term price fluctuations for CL.Check RDEN's competition here
Revlon, Inc. (NYSE: REV)
CL vs REV Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, REV has a market cap of 0. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas REV's P/E ratio is -1.19. In terms of profitability, CL's ROE is +6.31%, compared to REV's ROE of +0.89%. Regarding short-term risk, CL is less volatile compared to REV. This indicates lower risk in terms of short-term price fluctuations for CL.Check REV's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV-WT)
CL vs GROV-WT Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.31%, compared to GROV-WT's ROE of -0.83%. Regarding short-term risk, CL is more volatile compared to GROV-WT. This indicates higher risk in terms of short-term price fluctuations for CL.Check GROV-WT's competition here
Summer Infant, Inc. (NASDAQ: SUMR)
CL vs SUMR Comparison October 2026
Colgate-Palmolive Company (NYSE: CL) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.2B. In comparison, SUMR has a market cap of 0. Regarding current trading prices, CL is priced at $86.46 on the NYSE, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 23.06, whereas SUMR's P/E ratio is -3.66. In terms of profitability, CL's ROE is +6.31%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, CL is more volatile compared to SUMR. This indicates higher risk in terms of short-term price fluctuations for CL.Check SUMR's competition here